Dybbs Michael — SEC Form 4 filings
SEC reporting owner CIK 1601264. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-10 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SUTRO BIOPHARMA, INC. (STRO) | Director | 4 | — | — | 4 |
| Nkarta, Inc. (NKTX) | Director | 3 | — | — | 3 |
| Kalaris Therapeutics, Inc. (KLRS) | Director | 2 | — | — | 2 |
| SpyGlass Pharma, Inc. (SGP) | Director | 1 | — | — | 1 |
Form 4 filings — Dybbs Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 37,000 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 9,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | SpyGlass Pharma, Inc. (SGP) | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2025-12-29 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 1,500 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 46,000 (derivative) @ $0 | EDGAR |
| 2025-04-11 | 4 | Kalaris Therapeutics, Inc. (KLRS) | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Nkarta, Inc. (NKTX) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | SUTRO BIOPHARMA, INC. (STRO) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1601264 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →